ArticleJournal of autism and developmental disorders2026
Who Shapes National Autism Guidance? A Cross-National Comparison of Autism Guideline Development, Representation, and Implementation.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNational autism guidance increasingly shapes diagnostic practices and service pathways, yet comparative research has focused primarily on clinical content and methodological quality rather than the governance structures through which guidance is produced. We argue that differences in autism guidance are influenced not only by clinical recommendations but also by governance structure, lived-experience participation, and implementation architecture. This study examines how autism guidance is commissioned, who participates in development, and how guideline processes are linked to implementation across six countries: Australia, England, Norway, Scotland, Sweden, and the United States.
methodsUsing qualitative comparative document analysis, publicly available guideline documents and associated methodological materials were examined to assess each country's guideline authority, document function and scope, procedural transparency, lived-experience participation, implementation linkages, and relationship to broader national autism strategy. Participation was categorized along a spectrum from consultation to representation to co-production.
resultsThe analysis reveals substantial cross-national variation in how authority, participation, and implementation are structured within national autism guidance systems. Countries with centralized guideline authorities documented the most formalized mechanisms for incorporating lived-experience perspectives, while distributed or consultation-based models afforded less formal influence. Procedural transparency was generally high where centralized bodies existed but variable in distributed systems. Implementation linkages ranged from formal quality standards, indicators, and national strategy alignment to informal regional adoption.
conclusionThese governance differences are not fully captured by existing appraisal tools such as AGREE II. The findings provide a descriptive foundation for future research examining how governance arrangements influence autism guidance implementation, legitimacy, and impact.
Indexed as
Identifiers
42362933What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.